Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in Methyl-CpG-Binding protein 2 (MECP2), located on Xq28 and encoding a methyl CpG binding protein, are commonly related to Rett syndrome.
|
31647993 |
2019 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Different mutations in the gene implicated in RTT-<i>methyl-CpG-binding protein 2</i> (<i>MECP2</i>) establishes RTT as a disorder with divergent symptomatology ranging from individuals with severe to milder phenotypes.
|
28637735 |
2017 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Rett syndrome (RTT) is a rare neurodevelopmental disorder usually caused by mutations in the X-linked gene <i>methyl-CpG-binding protein 2</i> (<i>MECP2</i>).
|
28592917 |
2017 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Defects in methyl CpG binding protein gene (MECP2) largely accounts for RTT.
|
28857161 |
2017 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in MECP2 (MIM #312750), located on Xq28 and encoding a methyl CpG binding protein, are classically associated with Rett syndrome in female patients, with a lethal effect in hemizygous males.
|
27465203 |
2016 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Rett syndrome (RTT) is caused by mutations of MECP2, a methyl CpG binding protein thought to act as a global transcriptional repressor.
|
24094325 |
2013 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Rett syndrome (RTT) is mainly caused by mutations in the X-linked methyl-CpG binding protein (MeCP2) gene.
|
24453408 |
2013 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
RTT is associated with episodes of tachypneic and irregular breathing intermixed with breathholds and apneas and is caused by mutations in the X-linked MECP2 gene encoding methyl-CpG-binding protein.
|
23723037 |
2012 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The protein MeCP2 (Methyl CpG-binding protein) is an abundant component of pericentric heterochromatin and its mutations or duplications are present in around 80% of patients with a neurological disorder known as Rett Syndrome.
|
17965612 |
2007 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations of the MECP2 (methyl-CpG-binding protein) gene mainly cause Rett syndrome but were also shown to be involved in mental retardation.
|
17383248 |
2007 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the methyl-cytosine-phosphate-guanosine dinucleotide (CpG) binding protein 2 gene are identified in up to 90% of patients with classic Rett syndrome.
|
17903671 |
2007 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the MECP2 (methyl-CpG-binding protein) gene have been found to cause RTT.
|
16879196 |
2006 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the MECP2 (Methyl-CpG-binding protein) gene have been reported to cause Rett syndrome (RTT), an X-linked progressive encephalopathy.
|
16473305 |
2006 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome.
|
14618241 |
2004 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the MECP2 (Methyl-CpG-binding protein) gene recently have been reported to cause Rett syndrome (RTT), an X-linked progressive encephalopathy.
|
12180070 |
2002 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Recent genetic analyses have revealed that mutations in the methyl-CpG-binding protein gene encoding MeCP2 are associated with Rett syndrome.
|
11738866 |
2001 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the MECP2 (Methyl-CpG-binding protein) gene recently have been reported to cause Rett syndrome (RTT), an X-linked dominant neurodevelopmental disease.
|
11241840 |
2001 |
Rett Syndrome
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the methyl-CpG-binding protein gene MECP2 at Xq28 cause Rett syndrome (RTT), an X-linked dominant neurodevelopmental disorder characterized by a period of stagnation followed by regression in the development of young girls.
|
10767337 |
2000 |
nervous system disorder
|
0.020 |
Biomarker
|
group |
BEFREE |
The methyl-CpG-binding protein MeCP2 and neurological disease.
|
18631120 |
2008 |
nervous system disorder
|
0.020 |
GeneticVariation
|
group |
BEFREE |
The protein MeCP2 (Methyl CpG-binding protein) is an abundant component of pericentric heterochromatin and its mutations or duplications are present in around 80% of patients with a neurological disorder known as Rett Syndrome.
|
17965612 |
2007 |
Encephalopathies
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Mutations in the MECP2 (Methyl-CpG-binding protein) gene have been reported to cause Rett syndrome (RTT), an X-linked progressive encephalopathy.
|
16473305 |
2006 |
Encephalopathies
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Mutations in the MECP2 (Methyl-CpG-binding protein) gene recently have been reported to cause Rett syndrome (RTT), an X-linked progressive encephalopathy.
|
12180070 |
2002 |
Autoimmune Diseases
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Therefore, these data highlight that Cxxc1 as a key regulator governs the balance between T<sub>H</sub>17 and T<sub>reg</sub> cells by controlling the expression of IL-6Rα, which affects IL-6/STAT3 signaling and has an impact on T<sub>H</sub>17-related autoimmune diseases.
|
31633019 |
2019 |
Encephalomyelitis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mice with a T cell-specific deletion of Cxxc1 were protected from experimental autoimmune encephalomyelitis and were more susceptible to <i>Citrobacter rodentium</i> infection.
|
31633019 |
2019 |
Malignant neoplasm of stomach
|
0.010 |
Biomarker
|
disease |
BEFREE |
The CFP1 and 14-3-3 genes can be used as prognostic markers in patients with GC, but the study is still needed to confirm.
|
31496919 |
2019 |